STOCK TITAN

60 Degrees Pharmaceuticals: Orca reports 5.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

60 Degrees Pharmaceuticals, Inc. was the issuer in an ownership report by Orca Capital AG, which reported beneficial ownership of 222,934 shares of common stock, or 5.6% of the class. Orca's percentage calculation used 4,002,796 common shares and excluded 445,868 shares issuable upon exercise of warrants. The warrants are subject to a 4.99% blocker, which prevents exercise to the extent it would result in Orca beneficially owning more than 4.99% of the outstanding common stock.

Beneficial ownership 222,934 shares Shares of common stock reported by Orca Capital AG
Ownership percentage 5.6% Percentage of the class reported by Orca Capital AG
Common shares in percentage calculation 4,002,796 shares Aggregate common shares used to calculate ownership percentages
Warrant shares excluded 445,868 shares Common shares issuable upon exercise of warrants held by Orca Capital AG
Warrant exercise blocker 4.99% Exercise is limited where it would cause Orca Capital AG to beneficially own more than this percentage of outstanding common stock
beneficially owned regulatory
"222,934 shares beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
4.99% Blocker technical
"the 4.99% Blocker"
sole dispositive power regulatory
"Sole Dispositive Power 222,934.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SXTP shares did Orca Capital AG report owning?

Orca Capital AG reported beneficial ownership of 222,934 shares of 60 Degrees Pharmaceuticals, Inc. common stock, equal to 5.6% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





83006G401

(CUSIP Number)
11/05/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: All ownership percentages set forth in this Schedule 13G are calculated based upon an aggregate of 4,002,796 shares of Common Stock and excludes 445,868 shares of Common Stock issuable upon the exercise of warrants held by the Reporting Person, subject to the 4.99% blocker (defined below). Pursuant to the terms of the warrants, the Reporting Person cannot exercise any of the warrants to the extent the Reporting Person would beneficially own, after any such exercise, more than 4.99% of the Issuer's outstanding Common Stock (the "4.99% Blocker").


SCHEDULE 13G



Orca Capital AG
Signature:/s/ Thomas Konig
Name/Title:Thomas Konig/Director
Date:11/12/2026

Keep reading